Prognostic Value of C - Reactive Protein in Predicting Cardiovascular Outcomes among Patients with Acute Coronary Syndromes
Naogaon Medical College Journal · 31.08.2025 · 2 (2) · 74-78
DOI: 10.70818/nmcj.v02i02.026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naogaon Medical College Journal, online erschienen am 31.08.2025. Verfasst von AKM Fazlul Kader und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Acute coronary syndrome (ACS) remains a major cause of morbidity and mortality, and early identification of patients at increased risk of adverse cardiac events is essential. C-reactive protein (CRP), an established marker of systemic inflammation, may provide useful prognostic information in patients with ACS.
Objective
To evaluate serum CRP levels among patients with different forms of ACS and determine their association with subsequent cardiac events. Materials and Methods: This prospective observational study was conducted at Dhaka Medical College Hospital from January to December 2019. A total of 120 patients presenting with chest pain were enrolled and categorized into unstable angina (n=29), ST-elevation myocardial infarction (STEMI) (n=32), non-ST-elevation myocardial infarction (NSTEMI) (n=36), and non-cardiac chest pain/control (n=23) groups. Serum CRP, creatine kinase (CK), CK-MB, and troponin T were measured at admission. Patients were followed prospectively for 90 days to document mortality, recurrent myocardial infarction, unstable angina, and heart failure.
Results
Baseline demographic characteristics and cardiovascular risk factors were comparable among the groups (p>0.05). Mean CRP levels were significantly higher in STEMI (26.31±2.15 mg/L) and NSTEMI (25.7±1.6 mg/L) than in unstable angina (5.49±0.62 mg/L) and controls (2.3±0.27 mg/L) (p3 mg/L in unstable angina (p=0.028), STEMI (p=0.005), and NSTEMI (p=0.001). All NSTEMI patients with CRP >3 mg/L experienced cardiac events.
Conclusion
Elevated CRP was strongly associated with adverse cardiac events in ACS, suggesting that CRP may be a useful prognostic biomarker for risk stratification.
Zitieren
APA
Kader, A. F., Khatoon, R., & Kabir, M. H. (2025). Prognostic Value of C - Reactive Protein in Predicting Cardiovascular Outcomes among Patients with Acute Coronary Syndromes. Naogaon Medical College Journal, 2(2), 74-78. https://doi.org/10.70818/nmcj.v02i02.026
Vancouver
Kader AF, Khatoon R, Kabir MH. Prognostic Value of C - Reactive Protein in Predicting Cardiovascular Outcomes among Patients with Acute Coronary Syndromes. Naogaon Medical College Journal. 2025;2(2):74-78. doi:10.70818/nmcj.v02i02.026
BibTeX
@article{Kader2025,
author = {Kader, AKM Fazlul and Khatoon, Rabeya and Kabir, Mohammad Humayun},
title = {Prognostic Value of C - Reactive Protein in Predicting Cardiovascular Outcomes among Patients with Acute Coronary Syndromes},
journal = {Naogaon Medical College Journal},
year = {2025},
volume = {2},
number = {2},
pages = {74--78},
doi = {10.70818/nmcj.v02i02.026}
}
EUVIMED